RxDoctor Payments Data

Jenna Williford, PA

Physician Assistant · Alexandria, LANPI 1275885071

Payments from drug & device makers

$523in general payments, 2019–2025

Across 28 payments — averaging $18.70 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$155
  • Novo Nordisk$56
  • Dexcom, Inc.$54
  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$42
  • Bayer$32
  • Abbott$30
  • plus $155 from 9 others

What the payments were for

  • Food & beverage$49494%
  • Other$306%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$523 in reported general payments places this provider in the 55th percentile of 1,246 physician assistant providers in Louisiana.

See all physician assistant providers in Louisiana

Medicare billing

Part B allowed, 2024
$23,427
Medicare patients
123
Services billed
346

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide43$59,991
RybelsusSemaglutide31$50,645
MounjaroTirzepatide39$40,594
LinzessLinaclotide41$36,474
JardianceEmpagliflozin38$23,017
FarxigaDapagliflozin Propanediol24$17,639
EliquisApixaban16$15,177
TrulicityDulaglutide15$14,482
JanuviaSitagliptin Phosphate23$14,216
EntrestoSacubitril/Valsartan12$8,103
Anoro ElliptaUmeclidinium Brm/Vilanterol Tr11$5,306
SymbicortBudesonide/Formoterol Fumarate11$5,114
Albuterol Sulfate HfaAlbuterol Sulfate68$2,473
Varenicline Tartrate11$1,727
Pantoprazole Sodium104$1,187

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic, Rybelsus$56$110,63674 claims
Lilly USA, LLCMounjaro, Trulicity$17$55,07654 claims
AbbVieLinzess$155$36,47441 claims
Boehringer IngelheimJardiance$17$23,01738 claims
GSKAnoro Ellipta$13$5,30611 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 55th percentile of 1,246 physician assistant providers in Louisiana.

Other physician assistant in Alexandria

See the full list for Louisiana

Where these figures come from

Is this you, or does something look wrong? →